In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020

Yu-Lin Lee, Wen‐Chien Ko, Wen‐Sen Lee, Po‐Liang Lu, Yen‐Hsu Chen, Shu‐Hsing Cheng, Min‐Chi Lu, Chi‐Ying Lin, Ting‐Shu Wu, Muh‐Yong Yen, Lih-Shinn Wang, Chang-Pan Liu, Pei‐Lan Shao, Zhi‐Yuan Shi, Yao-Shen Chen, Fu‐Der Wang, Shu‐Hui Tseng, Chao‐Nan Lin, Yu‐Hui Chen, Wang‐Huei Sheng, Chun-Ming Lee, Hung-Jen Tang, Po‐Ren Hsueh